Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $4.53B | $160.23 | $185.67 | 15.88% | Strong Buy | 6 | 104.18% | 52.91% | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.54B | $16.42 | $31.20 | 90.01% | Strong Buy | 5 | 37.59% | 139.09% | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $12.35B | $130.63 | $160.09 | 22.55% | Strong Buy | 11 | 27.90% | 153.38% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.61B | $25.06 | $40.67 | 62.28% | Strong Buy | 3 | 13.79% | 24.89% | N/A | N/A | ||||
| GMAB | GENMAB A | $18.33B | $27.72 | $45.00 | 62.34% | Buy | 4 | 19.20% | 37.91% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.80B | $31.69 | $39.80 | 25.59% | Hold | 5 | 15.58% | 38.33% | N/A | N/A | ||||
| INCY | INCYTE CORP | $11.92B | $53.09 | $74.92 | 41.12% | Buy | 13 | 10.10% | 41.93% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.91B | $83.80 | $100.82 | 20.31% | Buy | 11 | 11.14% | 81.99% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $5.05B | $39.82 | $54.17 | 36.03% | Buy | 6 | 15.95% | 48.53% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $17.18B | $28.76 | $46.75 | 62.55% | Strong Buy | 4 | 11.31% | 34.87% | N/A | N/A | ||||
| VNDA | VANDA PHARMACEUTICALS INC | $269.28M | $4.68 | N/A | N/A | N/A | N/A | 13.15% | 102.06% | N/A | N/A | ||||
| AMLX | AMYLYX PHARMACEUTICALS INC | $135.56M | $2.00 | $11.00 | 450.00% | Buy | 5 | -49.09% | 142.34% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.44B | $22.12 | $27.14 | 22.71% | Buy | 7 | 7.86% | 56.43% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.89B | $109.29 | $193.27 | 76.84% | Strong Buy | 11 | 6.71% | 77.12% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $11.88B | $75.60 | $80.71 | 6.76% | Strong Buy | 7 | 6.42% | 29.33% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $239.26M | $4.96 | $7.00 | 41.13% | Buy | 1 | 2.23% | 67.87% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $21.93B | $92.24 | $114.71 | 24.36% | Hold | 7 | -10.50% | 36.84% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $1.11B | $7.50 | $12.33 | 64.44% | Strong Buy | 3 | 10.35% | 14.96% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.77B | $15.02 | $27.40 | 82.42% | Strong Buy | 5 | 16.35% | 16.52% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $559.33B | $124.02 | $133.00 | 7.24% | Strong Buy | 6 | 19.15% | 2.84% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $103.31B | $937.61 | $1.00k | 7.13% | Buy | 16 | 7.52% | 5.74% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.45B | $258.13 | $313.00 | 21.26% | Buy | 6 | 6.95% | 6.59% | N/A | N/A | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | $103.36B | $400.16 | $451.75 | 12.89% | Buy | 16 | 8.93% | 2.45% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.